AditxtScore™
Understanding the status of an individual’s immune system is key to developing and administering immunotherapies such as AditxtScore. We are commercializing a technology platform which provides a personalized comprehensive profile of the immune system. It is intended to be informative for individual immune responses to viruses, bacterial antigens, peptides, drugs, bone marrow and solid organ transplants, and cancer. It has broad applicability to many other agents of clinical interest impacting the immune system, including those not yet identified such as future infectious agents.
AditxtScore is being designed to allow individuals to understand, manage and monitor their immune profiles in order to be informed about attacks on or by their immune system. We believe AditxtScore can also assist the medical community in anticipating possible immune responses and reactions to viruses, bacteria, allergens and transplanted organs. It can be useful in anticipating attacks on the body by having the ability to determine its potential response and for developing a plan to deal with an undesirable reaction by the immune system.
We plan to utilize AditxtScore in our upcoming clinical trials to monitor subjects’ immune response before, during and after AditxtScore drug administration.
AditxtScore Advantages
AditxtScore offers a significant view of the immune system in a single test, rather than the current method of relying on multiple tests that lack insights into long-term immunity. The platform can also identify cellular responses, including determination of T cell activation, cytokine production, and B cell receptors (indicative of memory cells). This differentiation provides a unique opportunity to determine long-lasting immunity following natural infection or vaccination.
AditxtScore may also help other companies track the effectiveness of vaccine protocols by monitoring the patient’s immune response. The platform measures levels of multiple Ig isotypes against multiple viral antigens. The increased sensitivity and specificity of the assay lends itself to more accurate assessment of antibody levels and their change over time.
AditxtScore Technology Platform
A proprietary platform that provides a personalized comprehensive profile of the immune system which can assist the medical community in anticipating responses and possible reaction to viruses, bacteria, allergens, and transplanted organs.
Can be useful in anticipating attacks on the body by having the ability to determine its potential response and for developing a plan to deal with an undesirable reaction by the immune system.
Initial technology was licensed from, invented and used at Stanford University. It encompasses methods, systems and kits for detection and measurement of specific immune responses as described within the company’s U.S. Patent.
AditxtScore Technology Applications
First Application: AditxtScore for Covid-19
“The AditxtScore for COVID-19 has the potential to be a game changer for our industry. AditxtScore for COVID-19 is a multiplexed platform that has shown tremendous speed and accuracy, which is extremely critical for meeting the ongoing COVID-19 challenge.”
Harpreet Sandhu, CEO of Stanford Blood Center
Other Applications
- Infectious disease
- Allergies
- Organ Failure
- Disease susceptibility
- Drug vaccine response